Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial
Resource Type
Article
Authors
Davids, Matthew S ; Brander, Danielle M ; Kim, Haesook T ; Tyekucheva, Svitlana ; Bsat, Jad ; Savell, Alexandra ; Hellman, Jeffrey M ; Bazemore, Josie ; Francoeur, Karen ; Alencar, Alvaro ; Shune, Leyla ; Omaira, Mohammad ; Jacobson, Caron A ; Armand, Philippe ; Ng, Samuel ; Crombie, Jennifer ; LaCasce, Ann S ; Arnason, Jon ; Hochberg, Ephraim P ; Takvorian, Ronald W ; Abramson, Jeremy S ; Fisher, David C ; Brown, Jennifer R
Source
In The Lancet Haematology August 2019 6(8):e419-e428
Subject
Primary Research Articles
Language
ISSN
2352-3026